CMTM6 Overexpression Confers Trastuzumab Resistance in HER2-Positive Breast Cancer

Scientists uncovered a role of CKLF-like MARVEL transmembrane domain-containing 6 (CMTM6) in trastuzumab-resistant HER2+ breast cancer. CMTM6 expression was upregulated in trastuzumab-resistant HER2+ breast cancer cell.
[Molecular Cancer]
Full Article
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News